packageCatumaxomab

catumaxomab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Catumaxomab is a monoclonal antibody anticancer drug that was used to treat ascites caused by cancer. It was authorised in the European Union but its marketing authorisation was later withdrawn, so it is no longer in use.

Summary written by glm-5.3-flash from Wikidata Q408155 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:catumaxomab
ATC codes:L01FX03, L01XC09
DrugBank:DB06607
Wikidata:Q408155
molar mass:150511 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown